|
Apr 25
|
Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease
|
|
Apr 25
|
European Dividend Stocks To Consider In April 2025
|
|
Apr 23
|
Orion Group Interim Report January–March 2025
|
|
Apr 22
|
Invitation to Orion’s Capital Markets Day on 22 May 2025
|
|
Apr 9
|
Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025
|
|
Apr 3
|
Orion Corporation: Organising meeting of the Board of Directors
|
|
Apr 3
|
Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025
|
|
Mar 3
|
3 European Dividend Stocks To Enhance Your Portfolio
|
|
Feb 28
|
Orion Corporation: Managers’ transactions – Outi Vaarala
|
|
Feb 28
|
Orion Corporation: Managers’ transactions – Niclas Lindstedt
|
|
Feb 27
|
Orion Corporation: Managers’ transactions – Hao Pan
|
|
Feb 27
|
Orion Corporation: Managers’ transactions – Satu Ahomäki
|
|
Feb 25
|
Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company’s key persons
|
|
Feb 25
|
Orion Group Financial Statement Release January–December 2024
|
|
Jan 2
|
3 Leading Dividend Stocks Yielding Up To 8.5%
|
|
Dec 30
|
Orion and Marinus terminate agreement for ganaxolone in Europe
|
|
Oct 15
|
Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
|
|
Oct 14
|
Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
|
|
Jul 25
|
Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024
|
|
Feb 13
|
Notice to the Annual General Meeting of Orion Corporation
|